Page 3 - மூலக்கூறு உயிரி தொழில்நுட்பவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PatSnap - Patent Outsourcing: Outsourcing IP tasks Co-published Piya Jain Intellectual property is a corner stone in the long-term strategy of many companies, this is especially true for those in the life sciences space. Covid-19 was a hammer blow to the global economy and many life sciences firms were forced to reconsider their strategies, including with regard to acquisitions, research and development, and intellectual property. In 2019, biotechnology and pharmaceutical companies spent $306 billion on IP-related activities,  compared to only $140 billion in 2020,  a 54% decrease (Lexology). Although this slump might be alarming to some, with last year’s losses creating over $1.4 trillion in excess funds, 2021 is set to be a memorable year for intellectual property as the life sciences sector recovers.  

United statesEuropean unionHarvard collegev canadaMolecular biotechnologyHarvard collegeMolecular pathologyMyriad geneticsஒன்றுபட்டது மாநிலங்களில்ஐரோப்பிய தொழிற்சங்கம்மூலக்கூறு உயிரி தொழில்நுட்பவியல்ஹார்வர்ட் கல்லூரிமூலக்கூறு நோயியல்எண்ணற்ற ஜெநெடிக்ஸ்